In MM cells, CD38 is downregulated by IL-6, the major MM cell growth and survival factor secreted by BMSCs, via activation of IL-6-induced JAK1/2-STAT1/3 signaling pathways [39,40]. Here, STAT1 is linked to Miyoshi myopathy.